Cargando…
Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia
The return of blood flow to ischemic heart after myocardial infarction causes ischemia–reperfusion injury. There is a clinical need for novel therapeutic targets to treat myocardial ischemia–reperfusion injury. Here we screened for targets for the treatment of ischemia–reperfusion injury using a com...
Autores principales: | Heliste, Juho, Jokilammi, Anne, Vaparanta, Katri, Paatero, Ilkka, Elenius, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371130/ https://www.ncbi.nlm.nih.gov/pubmed/34404849 http://dx.doi.org/10.1038/s41598-021-96033-z |
Ejemplares similares
-
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
por: Heliste, Juho, et al.
Publicado: (2018) -
An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation
por: Vaparanta, Katri, et al.
Publicado: (2022) -
Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling
por: Kivelä, Riikka, et al.
Publicado: (2019) -
Human Metaplastic Breast Carcinoma and Decorin
por: Boström, Pia, et al.
Publicado: (2017) -
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
por: Narvi, Elli, et al.
Publicado: (2018)